StonvexLoading…
StonvexStonvexStonvexCore line items from MSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $124.22M | $58.04M | $55.40M | $41.98M |
Operating Income | $-1.27M | $-2.70M | $83.65K | $-826.59K |
Net Income | $1.17M | $-3.34M | $1.25M | $655.03K |
EPS (Diluted) | $0.07 | $-0.19 | $0.08 | $-0.04 |
Total Assets | $77.36M | $82.40M | $34.58M | $26.10M |
Total Liabilities | $65.72M | $71.68M | $33.79M | $26.95M |
Cash & Equivalents | $775.36K | $2.07M | $2.57M | $898.06K |
Free Cash Flow OCF − CapEx | $4.58M | $-3.89M | $434.80K | $1.43M |
Shares Outstanding | 17.75M | 17.91M | 16.00M | 16.00M |